Login Sign Up
Back to Feed
Infrastructure

Inside Cathie Wood’s ARK Innovation ETF: Tesla (TSLA), Coinbase, and AMD Lead the Pack

🤖 GG AI Summary

Cathie Wood's ARK Innovation ETF holds a concentrated portfolio of 46 stocks, with Tesla (10.46%) and AMD (5.66%) as its top positions, reflecting a strong focus on AI, gene therapy, fintech, and cryptocurrency infrastructure. The fund also includes significant biotech investments like CRISPR Therapeutics and crypto exposure through Coinbase and Robinhood. This diversified yet tech-centric approach highlights ARK's commitment to innovation and growth despite inherent volatility.

Sentiment: 78% Bullish

Key Takeaways Tesla commands the largest position in ARKK at 10.46%, with AMD following at 5.66% ARKK’s portfolio consists of 46 equities, with its top 10 positions representing slightly over 51% of total assets Crypto market exposure comes through Coinbase and Robinhood holdings Gene-editing companies CRISPR Therapeutics and Beam Therapeutics highlight ARK’s biotech commitment The fund’s investment thesis revolves around AI, gene therapy, financial technology, cryptocurrency infrastructure, and digital streaming Cathie Wood’s ARK Innovation ETF remains among the most closely monitored growth-oriented funds in the investment community. Current data from May 11, 2026, shows the fund managing a portfolio of 46 individual stocks, with its largest 10 positions comprising approximately 51% of total assets. The investment vehicle concentrates on enterprises driving technological disruption across multiple sectors. These include machine learning and AI, genetic medicine, blockchain technology, financial innovation, and emerging consumer platforms. The fund embraces concentration and accepts volatility as part of its strategy. Tesla commands the leading position with a 10.46% allocation. Wood has consistently maintained Tesla as a cornerstone holding due to its multifaceted exposure to electric transportation, self-driving technology, robotics development, and artificial intelligence capabilities. Tesla, Inc., TSLA Advanced Micro Devices claims the second position at 5.66%. This holding provides the fund with access to AI semiconductor technology, cloud computing infrastructure, and advanced processing capabilities — sectors experiencing substantial growth as AI investment accelerates. CRISPR Therapeutics occupies the third position with approximately 5% of the portfolio. This allocation demonstrates ARK’s sustained commitment to genetic engineering and targeted medicine, proving the fund extends beyond purely digital and AI investments. Tempus AI represents 4.80% of fun...

Comments